Haploidentical BMT With Post-Transplant Cyclophosphamide and Bendamustine
University of Arizona
University of Arizona
Sumitomo Pharma America, Inc.
Dartmouth-Hitchcock Medical Center
Memorial Sloan Kettering Cancer Center
Bellicum Pharmaceuticals
Bellicum Pharmaceuticals
University of Rochester
Medical College of Wisconsin
Medigene AG
Icahn School of Medicine at Mount Sinai
Bellicum Pharmaceuticals
Jonsson Comprehensive Cancer Center
Case Comprehensive Cancer Center
Celgene
Celgene
University College, London
University of Maryland, Baltimore
University of Pittsburgh
M.D. Anderson Cancer Center
Masonic Cancer Center, University of Minnesota
Masonic Cancer Center, University of Minnesota
Masonic Cancer Center, University of Minnesota
California Cancer Consortium
Massachusetts General Hospital
M.D. Anderson Cancer Center
Dana-Farber Cancer Institute
Yale University
Alliance for Clinical Trials in Oncology
Massachusetts General Hospital
National Cancer Institute (NCI)
4SC AG
Cellerant Therapeutics
Indiana University
Indiana University
University of Chicago
Rutgers, The State University of New Jersey
University of California, San Francisco
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Alaunos Therapeutics
Enzon Pharmaceuticals, Inc.
Northwestern University
Northwestern University
National Institutes of Health Clinical Center (CC)
NYU Langone Health
Fred Hutchinson Cancer Center
University of Arizona
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Rutgers, The State University of New Jersey